DS8201-a-U105 Trial of Trastuzumab Deruxtecan With Nivolumab in Patients With Urothelial Carcinoma – Matt Galsky
Matt Galsky (@MattGalsky) / X
Matt Galsky (@MattGalsky) / X
Updated Results on Adjuvant Immunotherapy in Muscle-Invasive Bladder Cancer | MedPage Today
Matt Galsky (@MattGalsky) / X
Breakthroughs in Bladder Cancer Immunotherapy, with Matthew Galsky - YouTube
The Uromigos: Bladder Cancer | GU Oncology Now
Intriguing' data may advance more personalized approach to muscle-invasive bladder cancer
Active Surveillance in Muscle Invasive Bladder Cancer
Matt Galsky (@MattGalsky) / X
Matthew Galsky, MD – Bladder Cancer Advocacy Network
Matt Galsky (@MattGalsky) / X
Matt Galsky (@MattGalsky) / X
Jonathan Rosenberg MD (@DrRosenbergMSK) / X
Matt Galsky (@MattGalsky) / X
Matt Galsky (@MattGalsky) / X
Galsky Discusses Ongoing Combination Immunotherapy Trials in Bladder Cancer
Matthew Galsky - Cancer (Oncology) | Mount Sinai - New York
Matthew Galsky, MD - Physician's Channel - Mount Sinai New York
Progress in PD-1/PD-L1 Inhibition in Bladder Cancer
Matt Galsky (@MattGalsky) / X
Dr. Galsky on Sequencing Questions in Urothelial Cancer - YouTube
Matthew D. Galsky, MD, Discussed Multidisciplinary Care for Treating MIBC With TURBT and Nivolumab Combo
Matt Galsky (@MattGalsky) / X
Matthew Galsky, M.D. | Science | AAAS
